Allogene Therapeutics Inc (NASDAQ: ALLO) Bullish Outlook Still Prevails With Short Term Targets At $33.5
Allogene Therapeutics Inc (NASDAQ:ALLO) does about 3.12M shares in volume on a normal day but saw 2107829 shares change hands in the recent trading day. The company now has a market cap of 247.16M USD. Its current market price is $1.13, marking a decrease of -4.24% compared to the previous close of $1.18. The 52 […]
Allogene Therapeutics Inc (NASDAQ: ALLO) Now Has A Market Cap Nearing $269.04M But Is Projected To Reach $7.32 billion By 2026
Allogene Therapeutics Inc (NASDAQ:ALLO) does about 3.19M shares in volume on a normal day but saw 3615299 shares change hands in the recent trading day. The company now has a market cap of 269.04M USD. Its current market price is $3190000.0, marking an increase of 3615299% compared to the previous close of $1.29. The 52 […]
Allogene Therapeutics Inc (NASDAQ: ALLO) Now Has A Market Cap Nearing $308.41M But Is Projected To Reach $7.32 billion By 2026
Allogene Therapeutics Inc (NASDAQ:ALLO) does about 3.33M shares in volume on a normal day but saw 2214437 shares change hands in the recent trading day. The company now has a market cap of 308.41M USD. Its current market price is $1.41, marking a decrease of -0.70% compared to the previous close of $1.42. The 52 […]